Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.

about

Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).

P2860

Q41927506-7C4A5213-C1FD-4B8C-9079-B1FC783D6D9F

P2860

Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.

Item

http://www.wikidata.org/entity/Q40332326

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Impact of Tenofovir on Hepatit ...... deficiency Virus Cohort Study.

@en

type

Item

label

Impact of Tenofovir on Hepatit ...... deficiency Virus Cohort Study.

@en

prefLabel

Impact of Tenofovir on Hepatit ...... deficiency Virus Cohort Study.

@en

P1476

Impact of Tenofovir on Hepatit ...... deficiency Virus Cohort Study.

@en

P2093

Alexander Lüthi

http://www.w3.org/2001/XMLSchema#string

Andrew Atkinson

http://www.w3.org/2001/XMLSchema#string

Andri Rauch

http://www.w3.org/2001/XMLSchema#string

Charles Béguelin

http://www.w3.org/2001/XMLSchema#string

Franziska Suter-Riniker

http://www.w3.org/2001/XMLSchema#string

Gilles Wandeler

http://www.w3.org/2001/XMLSchema#string

Nicole Friolet

http://www.w3.org/2001/XMLSchema#string

Patrick Schmid

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of tenofovir with and without interferon on hepatitis D virus replication in HIV-hepatitis B virus-hepatitis D virus-infected patients

Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study.

Treatment of hepatitis D.

Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection?

Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.

Use of alpha-interferon in the treatment of chronic delta hepatitis.

First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy.

Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients.

Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.

Higher rate of hepatitis events in patients with human immunodeficiency virus, hepatitis B, and hepatitis D genotype II infection: a cohort study in a medical center in southern Taiwan.

P304

1275-1278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIX125

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Darius Moradpour

Enos Bernasconi

Alexandra Calmy

Swiss HIV Cohort Study

P577

2017-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28199492

http://www.w3.org/2001/XMLSchema#string

Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.

about

P2860

P2860

Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698